Royal Bank of Canada
AGN

Royal Bank of Canada’s Allergan Inc AGN Stock Holding History

Royal Bank of Canada’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-149,189
Closed -$31.7M – 6814
2014
Q4 		$31.7M Buy
149,189
+12,885
+9% +$2.56M 0.02% 618
2014
Q3 		$24.3M Sell
136,304
-11,835
-8% -$1.97M 0.02% 710
2014
Q2 		$25.1M Sell
148,139
-111,415
-43% -$17.3M 0.02% 672
2014
Q1 		$32.2M Sell
259,554
-49,870
-16% -$6.07M 0.02% 510
2013
Q4 		$34.4M Buy
309,424
+90,026
+41% +$8.6M 0.02% 508
2013
Q3 		$19.8M Buy
219,398
+23,147
+12% +$2.08M 0.02% 738
2013
Q2 		$16.5M Buy
+196,251
New +$20.4M 0.01% 761

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Royal Bank of Canada's AGN Position: Q1 2015 in Review

Royal Bank of Canada sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 149,189 shares — an estimated $31.7M sold.

Royal Bank of Canada first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $34.4M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Royal Bank of Canada reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 149,189 Allergan Inc shares in Q1 2015, an estimated $31.7M.
  • Royal Bank of Canada first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Royal Bank of Canada's Allergan Inc position peaked at $34.4M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Royal Bank of Canada's 13F filing for Q1 2015, filed 15 May 2015.